Uterine cancer affects 28 in 100,000 women annually. Learn the 5 critical warning signs that could save your life and why ...

Immunotherapy is key for triple-negative breast cancer, but a new study finds Black women are receiving it less often than White women.

Women with the syndrome have difficulty getting pregnant and are at increased risk of miscarriage and uterine cancer, especially cancer of the endometrium. It is also common for affected women to ...

Women with the syndrome have difficulty getting pregnant and are at increased risk of miscarriage and uterine cancer, especially cancer of the endometrium. It is also common for affected women to ...

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with abnormal vaginal bleeding. It analyzes vaginal fluid collected on tampons for ...

Women with the syndrome have difficulty getting pregnant and are at increased risk of miscarriage and uterine cancer, especially cancer of the endometrium. It is also common for affected women to ...

Adding GLP-1s to progestin therapy appeared to reduce the risk for endometrial cancer among women with benign uterine or endometrial hyperplasia. Further research is needed to better understand ...

Two studies supported by the National Institutes of Health show a higher risk of developing uterine cancer among Black women and post-menopausal Black women who used the products extensively.

GSK’s PD-1 inhibitor Jemperli has been cleared for use by the NHS as a first-line treatment for a specific type of endometrial cancer, making it an option for around 580 women across England ...